Skip to content

DNLIDENALI THERAPEUTICS INC

CUSIP 24823R105 · common stock

3 tracked investors held DENALI THERAPEUTICS INC (DNLI) at the end of Q3 2026, worth $170.9M in total. The largest holder was Julian Baker, with 0.4% of its portfolio.

Holders · Q3 2026
3
New holders
0
Value held
$170.9M
Quarter-end price (est.)
$20.67

Investors holding DNLI · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
0.37%3,734,336$77.2MHOLD
Ken Fisher
Fisher Asset Management, LLC
0.01%2,460,545$50.9MADD+1.9%
Adar1 Capital Management
ADAR1 Capital Management, LLC
1.82%2,072,050$42.8MADD+101.3%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026300$170.9M$20.67
Q2 2026301$184.6M$25.72
Q1 2026400$155.6M$19.20
Q4 2025400$105.7M$16.51